Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review

The success of cancer immunotherapy with immune checkpoint blockade (ICB) has demonstrated the importance of targeting a preexisting immune response in a broad spectrum of tumors. This is particularly novel and relevant for less immunogenic tumors, such as breast cancer (BC), where the efficacy of I...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegrino, B., Musolino, A., Llop-Guevara, A., Serra, V., De Silva, P., Hlavata, Z., Sangiolo, D., Willard-Gallo, K., Solinas, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Review article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948367/
https://www.ncbi.nlm.nih.gov/pubmed/31901781
http://dx.doi.org/10.1016/j.tranon.2019.10.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948367/
https://www.ncbi.nlm.nih.gov/pubmed/31901781
http://dx.doi.org/10.1016/j.tranon.2019.10.010

Ejemplares similares